| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |